Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Towards a Closed-Loop Bioengineering Framework for Immersive VR-Based Telerehabilitation Integrating Wearable Biosensing and Adaptive Feedback.
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS.
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database.
Srrm2 haploinsufficiency drives SynGAP-γ reduction, Agap3 mis-splicing, and oligodendrocyte deficits in a genetic mouse model of schizophrenia.
Isolated Arterial Hypertension as a Rare Early Manifestation of Guillain-Barré Syndrome: A Case Report.
Modifiable risk factors and their joint impact on late-onset multiple sclerosis: Evidence from the UK Biobank.
Broadening the understanding of fatigue in multiple sclerosis: a qualitative study protocol of the EMA-FAMS project.
Updated systematic literature review and network meta-analysis of cladribine tablets versus currently approved disease-modifying treatments for active relapsing-remitting multiple sclerosis.
Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease.
Deep Learning-Accelerated 3D FLAIR Enables Reliable MS Lesion Detection.
Understanding Remission of Long-Term Conditions Through Electronic Health Records: Scoping Review.
Significance of Phrenic Nerve Conduction Study in the Electrodiagnosis of Guillain Barré Syndrome.
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
Effects of thoracic manipulation with trigger point therapy on inflammatory cytokine levels in individuals with multiple sclerosis: a pilot study.
Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review.
MicroRNA-mRNA Regulatory Network Associated with Cognitive Impairment in Multiple Sclerosis.
Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.
Peripheral nervous system safety signals of antibody-drug conjugates: cross-database reproducibility and labeling gaps identified using FAERS, JADER, and CVARD.
Geometry of the cumulant series in diffusion MRI.
Serpine1 regulates Th17 cell differentiation and exacerbates IMQ-induced skin inflammation.
A CSF disease-associated macrophage signature defines progressive multiple sclerosis.
Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison.
The relationship between digit ratio (2D:4D) and autoimmune diseases: A systematic review and meta-analysis.
Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.
Effectiveness and safety of ocrelizumab in relapsing-onset multiple sclerosis: A nationwide real-world study from Slovakia.
Pages
« first
‹ previous
…
958
959
960
961
962
963
964
965
966
…
next ›
last »